(CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis

NCT00679432 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

510

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

PROCEDURE: Blood sampling, endoscopy
DRUG: budesonide-MMX® 6 mg
DRUG: budesonide-MMX® 9 mg
DRUG: Placebo
DRUG: Asacol® 400 mg

Sponsor

Bausch Health Americas, Inc.